Role of Residual Urine and Asymptomatic Prostatitis in the Development of Urinary Tract Infections in Spinal Cord Injury

November 21, 2016 updated by: Swiss Paraplegic Centre Nottwil

Role of Residual Urine and Asymptomatic Prostatitis in the Development of Lower Urinary Tract Infections in Spinal Cord Injury Patients - a Prospective Study

The purpose of this prospective study is to investigate the association between the amount of residual urine and asymptomatic bacterial prostate infection with the occurrence of recurrent (>2 /year) symptomatic urinary tract infections in patients suffering from chronic (> 1 year) spinal cord injury (SCI) and neurogenic lower urinary tract dysfunction performing intermittent catheterization.

The following hypotheses will be tested:

  1. The amount of residual urine after intermittent catheterization is significantly greater in SCI patients suffering from frequent (>2 /year) urinary tract infections compared to those without.
  2. The incidence of asymptomatic bacterial prostate infections is significantly higher in SCI patients suffering from frequent (>2 /year) urinary tract infections compared to those without.

Study Overview

Detailed Description

To investigate the association between the amount of residual urine and asymptomatic bacterial prostate infection with the occurrence of recurrent (>2 /year) symptomatic urinary tract infections in patients suffering from chronic (> 1 year) spinal cord injury (SCI) and neurogenic lower urinary tract dysfunction performing intermittent catheterization, patients perform self-catheterization twice (before and after urodynamic testing. After each catheterization, residual urine is assessed by ultrasound. Prior to urodynamic testing, prostate massage is performed, bacterial cultures of the fluid and the urine are initiated and the results of these cultures will be analysed .

Study Type

Observational

Enrollment (Actual)

60

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

    • LU
      • Nottwil, LU, Switzerland, 6207
        • Swiss Paraplegic Centre

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

14 years to 66 years (Adult, Older Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Male

Sampling Method

Non-Probability Sample

Study Population

Male patients with chronic (> 1 year) spinal cord injury who perform intermittent catheterization due to neurogenic bladder dysfunction

Description

Inclusion Criteria:

  • male patients with chronic (> 1 year) spinal cord injury
  • bladder management by intermittent catheterization

Exclusion Criteria:

  • symptomatic urinary tract infection
  • prostate pathology
  • immunodeficiency
  • antibiotic therapy
  • missing informed consent

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Observational Models: Cohort
  • Time Perspectives: Prospective

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
urinary tract infection
urinary tract infection in male patients with neurogenic bladder dysfunction due to spinal cord injury managed by intermittent catheterization
residual urinary volume assessed by ultrasound after bladder catheterization urinary cultures taken before and after prostate massage
Other Names:
  • ultrasound
  • intermittent catheterization
control group
less than three urinary tract infections / year
residual urinary volume assessed by ultrasound after bladder catheterization urinary cultures taken before and after prostate massage
Other Names:
  • ultrasound
  • intermittent catheterization

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
amount of residual urine
Time Frame: change from self-catheterization 10 minutes before and 10 minutes after urodynamic assessment
determined by ultrasound
change from self-catheterization 10 minutes before and 10 minutes after urodynamic assessment

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
patient characteristics
Time Frame: day 0
age
day 0
patient characteristics
Time Frame: day 0
sex
day 0
bacterial prostate infection
Time Frame: 5-10 minutes before and after prostate massage
urinary culture
5-10 minutes before and after prostate massage
bacteriuria
Time Frame: 5-10 minutes before and after prostate massage
urine dip stick
5-10 minutes before and after prostate massage
number of leucocytes in urine
Time Frame: 5-10 minutes before and after prostate massage
urine dip stick
5-10 minutes before and after prostate massage
number of erythrocytes in urine
Time Frame: 5-10 minutes before and after prostate massage
urine dip stick
5-10 minutes before and after prostate massage
type of neurogenic bladder dysfunction
Time Frame: day 0
day 0
type of catheter used for intermittent catheterization
Time Frame: day 0
day 0
annual rate of symptomatic urinary tract infections
Time Frame: day 0
day 0
patient characteristics
Time Frame: day 0
time since spinal cord injury
day 0
patient characteristics
Time Frame: day 0
level and degree of spinal cord injury (ASIA impairment score)
day 0

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Investigators

  • Principal Investigator: Jürgen Pannek, Prof., Swiss Paraplegic Center, Nottwil, Switzerland

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start

December 1, 2011

Primary Completion (Actual)

February 1, 2013

Study Completion (Actual)

February 1, 2013

Study Registration Dates

First Submitted

May 1, 2012

First Submitted That Met QC Criteria

May 15, 2012

First Posted (Estimate)

May 17, 2012

Study Record Updates

Last Update Posted (Estimate)

November 22, 2016

Last Update Submitted That Met QC Criteria

November 21, 2016

Last Verified

November 1, 2016

More Information

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Urinary Tract Infection

Clinical Trials on sonographic assessment of residual urine, urine culture

Subscribe